Biotech Business 2132 Views Galecto raises $64 million to accelerate development of clinical pipeline Malin Otmani September 29, 2020 Galecto has announced the completion …
Clinical Trials 1576 Views Galecto’s oral galectin-3 Inhibitor well tolerated in Phase 1 Malin Otmani September 17, 2020 Galecto’s oral small molecule galectin-3 …
Pharma Business 1605 Views Galecto receives US and EU orphan drug designation Malin Otmani September 1, 2020 Galecto has received Orphan Drug …
